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INTRODUCTIONa
Historically the interest in organic derivatives of selenium
has been primarily centered on selenium analogs of sulfur compounds,

!•.!!.••

the selenium analogs of the sulfur-containing amino acids.

Experimental studies of the metabo1ism of seleno-organic compounds have
been limited to a large extent by their unavailability.

Dimethyl

selenide is the only organic selenium compound that has been identi
fied as an exhalation product from a laboratory animal injected with
an inorganic form of· selenium.1 •
Although the toxicity of selenium has been known for many
years, the mode of action of the element has remained a mystery.

Many

investigations on the toxicity of selenium have been concerned only
with selenium analysis of the excreta of livestock and/or laboratory
animals in an attempt to establish a detoxification pathway for
selenium.

Isolation and identification of excreted selenium compounds,

with the exception of selenite or selenate_, have bee1:1 extremely diffi-
cult.
A recently identified seleno�organic compound2 , isolated from
rat urine after oral and intraperitoneal administration of subtoxie
levels of selenite, gave occasion for this study.

The compound identi

fied as a trimethylselenonium moiety was studied in the chloride formb.
aThe writ ing style or· the journal Biochimica
was used as the guide in preparing this thesis.
bHereafter referred to as TMSe or TMSeCl.

.tl

Biophysica �
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This study was originally undertaken to help clarify the path
way of selenium detoxification in the· rat by investigating the
metabolism of the newly identified excretory product (TMSe moiety).
A complete metabolic investigation of a selenium compound
should answer the following questions:

(1) Is the compound metabo

lized to a volatile product, at what rate is this volatile product
excreted from the lungs, and what percentage of the administered dose
is eliminated in this way?

(2) Is it or one of its metabolic products

excreted in the urine, at what rate is the selenium excreted, am what
percentage.of the administered dose is excreted in the urine? (J) Is
it or a metabolized product present in the feces and what percentage of
the administered dose is eliminated in this way?

(4) Is selenium re

tained in t�e animal, to what degree, and what is the distribution of
the retained selenium in the ·animal?
toxic?

(5) Is the compound itself

If so, at what. selenium concentration.

During the study of qu,estions- one and two above�- it was
discovered that the �ompound (or a metabolized product of it) was
itself toxic--al.though at quite high selenium concentrations--and
further work was then done to answer question number five.
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LITERATURE REVIEW
Since this study deals with questions one, two, and five
brought forth in the Introduction, this literature review will be
devoted to previous investigations concerned with answering these same
questions for other selenium c�mpounds.
Exhalation
The amount of volatile selenium recovered after administration
of various forms of selenium depends on the form administered, the
dosage administered, dietary history of the animal, animal age, and
the simultaneous or near simultaneous administration of protective
agents, !_._g_., arsenic.
Schultz and Lewis3 studied the excretion of volatile selenium

after sodium selenite (2.5-J.5 mg Se/kg body wt.) was injected

subcutaneously into adult male rats. They found that 1?-52% of the
injected selenium was excreteq within 8 hours.

They further found

that the excretion of the volatile selenium co�pou.nd was not increased
by the administration of methyl group donors such as methionine or
choline chloride. Hofmeister4 had postulated without experimental
evidence that one of the volatile compounds was dimethyl selenide.
Methyl donors might be expected to assure more ready methylation of
the selenium to dimethyl selenide.
McConnell and Portman1. later established that dimethyl selenide

was a volatile excretory product of selenium metabolism in the rat
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after injection of sodium selenate. It has not, however , been proved
to be the only volatile selenium excretory product.
Using radioactive selenium McConnell5 did a study of the rate
of selenium exhalation on rats after subcutaneous injection of a
single subtoxic dose of sodium selenate (J-4 mg Se/kg body wt.).

It

was found that J-10� of the or'iginal dose was exhaled wi. thin 24 hours,
and approximately 75% of this a�ount was exhaled during the first 6

hours.
McConnell and.Roth6, examining the dose-excretion relationship,
performed experiments to determine the correlation between the amount
of selenium administered as either (75se)selenite or (75se)l-seleno

methionine and that excreted in the respiratory gases. They demon
strated that the formation and excretion of volatile selenium compo�ds
occurs soon after the administration of (75se)selenite and (75se)l

seleno methionine; that the rate of excretion of volatile substances
through the �ungs when·admintstering either form is mofe r apid during
the first 6-hours than during any subsequent 6-hour period up to 24
hours; and on the basis of mg Se/kg. body wt., larger amounts of
selenium are excreted when administered as inorganic than as organic
selenium.
excretion

They concluded that ·the mechanism of methylation and rapid

fil

the respiratory gases_ assumes a more significant

detoxification role when amounts of selenium approaching lethal levels
are administered.
The effect of dietary history on the elimination of volatile
selenium compounds was reported by Ganther and Bauman?.

They found

5
that rats injected with 2.0 mg Se/kg body wt. as sodium selenite
exhaled as much as 40� or the injected selenium within 10 hours when
maintained on a crude diet (Purina Chow). Exhalation by rats on such
•diets was usually about double that by rats fed a purified diet.
Kamstra and Bonhorst8 first reported the effect of arsenic on
the expiration of volatile selenium compounds. Rats injected with
sodium selenite (2.5-J.2 mg Se/kg body wt.) and either J.0 or 4.0 mg
As/kg body wt. as sodium arsenite were shown to exhale significantly
less volatile seleniUm than when only sodium selenite was injected.
Olson

tl !1_.9

conducted an extensive study on the effect of

arsenic on selenium metabolism in rats. Their work confirmed that

of others7, B in that arsenite markedly reduces the exhalation of

selenium by-rats injected with selenium at a level approaching an
acutely toxic dose (2.0 mg Se/kg body wt.).

Both arsenite and

arsenate were found effective when injected in combination with either
selenite or selenate. They furthe� confirmed that the ·rat is more

efficient in �onverting selenite to the volatile form than it is in
converting selenate�
Olson

tl

al.9 also showed that as the level of injected selenium

is decreased the percentage exhaled falls off rapidly. The effect of
arsenic injected prior to selenium injection appeared to decrease
gradually as its level of injection was decreased, the level or
selenium remaining constant.·
Levander and Bauman1° in a study to determine the effect of
arsenic on selenium metabolism found that sodium arsanilate (10 mg

6
As/kg body wt. ) increased the amount of selenium eliminated

.::i!

the

lungs when sodium selenite (2.0 mg Se/kg body wt. ) was injected subcu
taneously.

In the authors• opinion, this does not seem to be relevant

to the prophylactic action of arsenic against selenium toxicity since
the inorganic forms of arsenic which alleviate selenium toxicity
actually inhibit selenium volatilization.
Selenium may be eliminated by the respiratory tract in chronic
as well as in acute selenosis.

Studies dealing with the respiratory

elimination of selenium in chronic selenosis have not been cotrlucted,
but indirect evidence indicates that in chronic selenosis the detoxi
fication mechanism by respiration is more active than when a toxic
dose of selenium is given.

Balance studies on selenium in chronic

selenosis i� rats produced by 1. 4 mg Se/kg body wt. (selenite) given
intragastrically indicate that from 50-70'%> of the administered dose
could not be accounted. for by fecal or urinary excretion or by deposi
tion in the tissues11. · Ther�fore, the remainder most likely was
eliminated by the re�piratory tract·(elimination of selenium by the
sweat glands is also known to occ�r)11 •
Urinary Excretion

or volatile
or selenium.

'The factors that ai'fect the excretion
compounds also affect the urinary excretion
Munsell

tl £. 12

selenium

fed rats selenized wheat containing 9 ppm

selenium for 6 to 11 weeks and found that from 25 to
ingested selenium was excreted in the urine.

49%

of the

7
Smith � al.. 1 3 administered sodium selenite to cats orally and
subcutaneously in doses of 0. 02, 0. 10, and 0. 25 mg Se/kg body wt. over
an observation period of from 15 to 188 days.

They found that from 28

to 90%, and usually 50 to 80%, of the ingested dose was excreted in the
urine.

They pointed out, in general, that the percent excreted is

higher for the smaller doses (0. 02 and 0. 10 mg) than for the larger
and definitely toxic dose of 0.25 mg.

Also, the percent of selenium

excreted in the urine appeared somewhat higher in animals receiving
the selenium subcutaneously than in those receiving it orally.

In

a iater paper, Smith

!i

al. 1 4 showed that trJhen cats were fed

selenium-containing wheat gluten the urinary excretion of selenium was
approximately 40% of the total ingested dose (the ingestion dose being
0. 10 mg Se/kg body wt. ).

The authors, in comparing this result wit�

that previously obtained from cats fed sodium selenite, stated that
equivalent doses of selenium chronically administered in organic
combination result in relatively lower concentrations of selenium in
'

.

the urine than when administered in•inorganic form.
This is not in agreement with results obtained by-Moxon and his
co-workers15.

They compared the ur.inary excretion of selenium by rats

administered as seleniferous wheat, selenocystine, and sodium selenite
(selenium content of the diet being_ 18 ppm in all rations).

No

significant difference was found in the percentage of ingested selenium
excreted in the urine by animals on the different rations.
over a six-week period the percentages increased about 50%.

However,
This

increased selenium elimination was explained to be due eithe r to the

8

increasing age of the rats, since old rats have been found to be more
resistant to selenium poisoning, or to physiological factors which
limit

the a.mount of selenium retained on continual administration.

-It should be noted, however, that the two studies in question were
done with different animals.

McConnenl6 studied the· urinary excretion of selenium by

injecting (?5se)sodiurn selenate (0. 25-0. ?8 mg Se/rat) in a single
He found that the selenium was excreted

subcutaneous injection.

primarily by way of the kidneys in a nonvolatile, ether-insoluble
form, which indicated to him that the selenium was excreted in an
inorganic form.

Forty-one to 43� of the original dose appeared in the

urine during the first 24-hour period.
Peter.sen

tl &. 1?

found no significant variation in urinary

selenium excretion when ar�enic was included in the selenium diet of
rats (1. 4 mg sodium selenite/kg body wt. plus 1. 0 mg sodium arsenite/kg
1he percentage recoveri_es were very small: . sel enium diet
.
only, 1. 5%; ·selenium-plus arsenic diet, 1. 7�.
.
body wt. ).

.

Ganther and Bauman? confirmed the lack of

any

arsenite effect

on the urinary excretion of sel enium when young adult male rats were
injected with (75se)sod.ium selenite (1 . 5 mg Se/kg body wt. )

2. 9 mg As/kg body wt.
only.

and

2. 5 to

The radioacttvity was present in tracer amounts

Further, excretion Yi,! the urinary tract did not appear·to

differ greatly when either a · purified or a crude diet was fed.

Their

9
results were as follows0:

purified diet, 13.2/12.9�; crude diet,

15.9/17.9% for a 24-hour period.

Olson and co-workers9 , studying the effect of arsenic on
_selenium metabolism, followed the urinary excretion of selenium by
rats on a selenium diet (5 ppm selenium as sodium selenate).

Again,

no difference was found between a group fed only selenium and another
group fed the selenium diet plus 0.015� arsanilic acid. Approxi
mately

49%

of the injected selenium was recovered during a 4-day

collection period.
The above-mentioned investigations show so many vari ations in
kinds of animals used, dosages, methods of ad.ministration, and types
of arsenic and selenium compounds used that comparisons of the results
cannot readily be made.
Acute Toxicity
Acute selenium poisoning in laboratory animals is produced by
a single toxic dose of a selenium compound administereci · orally,
subcutaneously, intraperitoneally,. or intravenously.
The toxicity of selenium in different forms has been studied
by several investigators.

Rosenfeld and Beath11 have reviewed the ·

literature and tabulated the results of most investigators.

An

examination of that report shows that there is some disagreement in the
literature on the minimum lethal dose for various animals.

The

CThese were calcula ted from the reported data for comparison
purposes only and represent the average percent selenium recovered of
the injected dose for the particular diet and for the diet plus
arsenite.

10
different results may have been due to species differences or
variation in age of the animals.

Another factor contributing to

inconsistencies in the literature is the lack or· a standard criterion
for minimum lethal dose.
The relative toxicities of selenite and selenate to rats were
compared by Franke and Moxon18 • · Their results, using intraperitoneal
injections, indicated a minimu.� lethal dose of 3.5 mg Se/kg body wt.
with selenite and

5.J mg/kg with selenate. The term minimum lethal

dose as defined by Fran.�e and Moxon is the dose which will kill at
least 75<% of the animals within 48 hours.
Smith!.!:, al. 19 duplicated Franke and Moxon's work and found no
appreciable difference between the toxicity of selenite and selenate
to rats.

They did, however, observe that the action of a lethal dose

of selenate was usually more rapid and the rats seldom survived beyond
12 and 18 hours, while deaths from selenite were sometimes delayed for
several days.
As mentioned ;in the Introduction, experimental studies of the
toxic effects of organic selenium compounds are limited.

Several

organic seleniu.m compounds have been tested as to their acute toxic
effects20, 21 , 22 •

Of most importance are the selenium analogs of the

sulfur-containing amino acids.

The minimum lethal dose of dl

selenocystine injected intraperitoneally was investigated by Moxon21
and found to be 4. 0 mg Se/kg-body wt.

tl al. 23

Subsequent work by Moxon

showed that 1-selenocystine was more toxic than the d-form

when given orally and that arsenic gave full protection against the

11

toxicity of the analogs just as it does against the toxicity of the
selenium in seleniferous grains.

From these results, they concluded

that selenocystine is one of the more important, if nQt the most
important, carriers of selenium in seleniferous cereals.

The minimum

lethal dose of selenomethionine by intraperitoneal injection in rats
was found to be 4. 2 5 mg Se/kg .body wt. 23 .
Investigations as to the acute toxic effects of dimethyl
selenide indicate that it has a low degree of toxicity.in the rat.

The LD50 by intraperitoneal injection is 1.6 g Se/kg body wt. 24.

These workers concluded that detoxification of selenium in the animal
body proceeds from a highly toxic form to a less toxic compound which
is eliminated through the respiratory tract.
Acute toxicity of elemental selenium has not been investigated
in detail.

Rosenfeld and Beath11 concluded that elemental selenium

is not toxic owing to its relative insolubility.

In

explaining the mechanism of acute selenium toxicity some

workers have postulated that certain key enzymes are inhibited.
this regard, Klug

ll

In

-

al� 2 5 investigated the effect of a number of

seleno-compounds on the activity of succinic dehydrogenase of rat liver
homogenates.

Of a series of seleno-compounds, selenocystine was the

most toxic and selenomethionine the least toxic.

There was no correla

tion between the degree of enzyme inhibition!!!, vitro and the toxicity
of seleno-compounds in intact animals •.

A complete description of the symptoms of acute selenium

poisoning in the rat does not appear in the literature.

The following

12
summarized description is from Franke and Moxon18 •

Within a few

minutes after injection of selenate or selenite the rats began to
exhale odoriferous compounds in the breath.

Rats injected ld th

selenite usually exhibit spasmodic contraction of the flanks from time
to time and appear· to be in acute distress during the contractions.
With larger doses respiration becomes increasingly difficult and the
rats become cyanotie and die gasping for breath.

In

some cases there

appears to be a complete anesthesia just before death while in others
there is a convulsive struggle.

Symptoms caused by injecting selenate

resemble quite closely those caused by selenite.
Gross pathological data on acute selenium poisoning in
laboratory animals are not very extensive.

Jones26 described the liver

as being soft and pliable, the right auricle of the heart distended and
full of clot, and the splanchnic ve�sels enormously dilated.
Chronic Toxicity
Chronic sel.enium poisoning _in laboratory animals may be
produced by the administration of
period of time.

small repeated doses over a long

The selenium may be given orally or by intraperitoneal;

intramuscular, or subcutaneous administration.

The poisoning may be

produced by using inorganic selenium compounds, natural seleniferous

grains or plants, or artificially �elenized crops grown in soils

treated with selenium salts or with seleniferous plant extrao-tsll .

There is considerable individual variation in susceptibility to

the toxic effects of selenium.
selenium are cumulative.

In chronic selenosis the effects of

Cumulative effects of irrlividual doses may
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be produced by 16-50% of the minimal lethal dose.

The wide range is

due to individual variations in susceptibility and not to lack of
absorption or excretion , as the same variations exist when selenium is
_injected intravenouslyll. The comparative results of all studies
indicate that individual variations must be related to some detoxi
fication mechanism which functions with greater efficiency in some
animals11 •
On

repeated administration of ch:ronic doses of selenium there

is a continual increase in the manifestation of the disease which
suggests that there is no altered susceptibility or acquired tolerance
which would account for individual variations.

In addition to

individual variations, there is a difference in susceptibility with
age.

Younger rats are more susceptible to selenium than older animals.

The life span of younger animals is greatly reduced while older animals
fail to gain weight.

Small differences in age and weight of animals

may have a greater effect on susceptibility than the possible differ-.
ences in the toxicity of the compound testea11 •
.
Franke and Painter27 , in a study which included the feeding of

many different seleniferous diets to rats, made the following
conclusions:

(1) If selenium was the only toxicant in the diets, ·the

relative toxicity of selenium in the different forms is (from highest
to lowest):

wheat, corn, barley, selenate, and selenite.

(2 ) There

is a pronounced restriction of food consumption in every diet contain
ing over 10 ppm of selenium as it occurs in the diet.

(3 ) Concentra

tions of less than 5 ppm of selenium in the diet are sufficient to

2 3 3 o.5 G SOUTH DAKOTA STATE U1 VE R ITY LIBRARY
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prevent normal growth.
in young animals.

(4) In general, 9 ppm of selenium cause deaths

Further, it is probable that on1y naturally

occurring selenium will regularly cause deaths at this level.

(5) Female rats are slightly more susceptible to selenium poisoning

than males.

(6) There is no relationship between the absolute amount

of selenium consumed per day and observed toxic effects. The effect
of seleniferous diets appears to depend more on the concentration of
selenium in the diet than upon the quantity of selenium consumed per
day.

'!his same paper also substantiates the fact that the toxic

manifestation of inorganic selenium compounds and seleniferous grains
are almost identical under similar experimental conditions.
Moxon28 was the first to observe that arsenic prevents the
characteristic symptoms of selenium poisoning in rats. In experiments
to determine the toxicity of selenium in combination with several
other elements, he found that the addition of 5 ppm arsenic as sodium
arsenite to the drinking water gave · full protection against liver
damage caused by 15 · ppm of selenium in the fom of seleniferous wheat.
He also found that arsenic protected against liver damage and the
general toxic effects of inorganic selenium.
Moxon tl al.29 disprove� the theory that arsenic protects
against selenium toxicity in inhibiting the absorption of selenium from
the gastrointestinal tract by demonstrating that detoxification was
independent of the route of administration of either selenium or
arsenic.
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Chronic selenosis in rats is characterized by marked loss in
body weight and anorexia followed by eachexia.

Ascites and edema may

Ascites and edema also may develop

develop under identical conditions.

after the discontinuation of small chronic doses of selenium, provided
the duration of administration is sufficient to produce damage to the
liverll .
The gross pathological changes due to chronic selenium poisoning
depend upon the duration and dose of the toxic substance.

In the truly

chronic· cases the outstanding pathology occurs in the liver.

The

liver is hard, nodular, and shrunken in size, showing nodular
cirrhosis.

Varying degrees of atrophy and necrosis are present.

The heart and spleen are enlarged.
present.

Jaundice may or may not be

The thymus and gonads show atrophy.

Ascites and edema are

commonll .
Trimethylselenonium Production
Palm._er

tl .2:1• 2,

during their work to. identify �Se, studied the

effect of level of -selenite on the.production of TMSe and a.lso the
effect of sodium arsenite on its production.

They concluded that 'flv1Se

is a normal metabolite because it is.excreted at both low and high
levels of selenium (2 micrograms Se and 0 . 8 mg/kg body wt. ) .

To

further substantiate their conclu�ion, they had evidence that TMSe is

an important excretory product whether selenite was administered orally

or by injection.

They found a statistically significant effect of

arsenite on the production of TMSe only at . the higher level of selenium
used in their experiment (0 . 8 mg Se) .

At this level of selenium plus

16
2 mg As/kg body wt. they found that significantly less (P <0.05) TMSe
was produced.

Because they did not get this statistical
significance
.
at the lower level, they suggested that there was still some doubt as
.

to the effect of arsenic on TMSe production and that higher levels of
selenium should be· administered before final. judgment is made.
This study examined th� fate of TMSeCl in relationship to its
metabolism to a volatile product.

The study al.so examined both the

acute and chronic toxicity of TMSeCl.

Finally, the effect of arsenite

on the production of TMSe from selenite on the volatilization of
selenium from TMSeCl and on the toxicity of TMSeCl was investigated.
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EXPERIMENTAL PROCEDURES
Materials
The rats used in the various experiments were all males of the
Sprague-Dawley strain.
on-experiment.

They were all fed Purina rat chow until placed

The rats when used in experiments involving injection

into the peritoneal cavity were starved overnight--approxi.m.ately 18
hours.

The radioactive selenium used was obtained from Nuclear Science

in the form of H275seo3 .

used.

Analytical reagent grade sodium arsenite was

The sodium selenite was prepared and purified according to the

procedures of Trelease and Beath30.

degree of purity.

Its analysis indicated a high

The basal diet used in the chronic toxicity study

contained the following in percent:

dextrose, 67. 8; purified casein,

20. 0; corn oil, 5. 0; USP salt mixture, 5 . 0; and vitamin mixture, 2�2•
The TMSeCl was prepared by refluxing dimethyl selenide with methyl
iodide.

The TMSeI fomed was run through a Dowex 2 chloride-form anion

exchange resin column to exchange a chloride ion for the iodide ion.
The TMSeCl ·collected was recrystaliized

3

times from methanol.

Selenium analysis of the TMSeCl, using the Watkinson method3 1,
indicated the compound was 99% pure. · NMR spectra indicated no organic
contamination.

The dimethyl selenide was prepared according to the

procedures of Bird and Chil.lenger3 �.

Dimethyl sulfide used in prepara

tion of trimethylsulfonium chloride was prepared according to
procedures outlined by ReidJ3.
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Exhalation Study
F.quipment used to house the rats while collecting exhaled
selenium consisted of an opaque wide mouth jar of about 4 liters
volume.

The jar was connected to an all-glass absorption bottle.

The bottle was fitted with a sintered glass inlet and contained 175
ml of concentrated nitric acid.

The absorption bottle was in turn

connected to a vacuum source adjusted to draw air through the system
at the rate of 800 ml/min.

Preliminary work indicated one absorption

bottle �as sufficient to trap the volatile selenium.

All connections

were of glass or tygon tubing with the exception of a two-hole rubber
stopper which covered the mouth of the opaque jar.

A piece of glass

tubing extending through the rubber stopper and to the bottom of the
jar provided the air supply.

Three such systems were built and used

at random on different days with rats injected with various doses of
TMSeCl.

This was done to· insure that the effect observed was

attributable to the treatment appli·ed and not the result of any

system . or
day-to-day environmental changes.
uniqueness . of a · particular
.
.
To determine whether there was a diffe�ence in the amount and
rate of selenium exhaled when rats were injected with TMSeCl as
compared to selenite, rats were injected intraperitoneally with sodium

selenite or TMSeCl at levels ranging from 1. 5-40. 0 mg Se/kg body wt.
To determine whether or not arsenic affects the volatilization of
TMSeCl selenium, sodium arsenite was injected intraperitoneally 10
min. prior to the selenium at either · 2 or 4 mg As/kg body wt.

The

rats ranged in weight from 143 to 277 g with an average weight of 189
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g.

Immediately after the selenium injection, the rats were placed in

the jars and the collection of volatile selenium was started. At 1,
J, and 6-hour intervals 15 · m1 aliquots were removed .from the
absorption bottles and analyzed for selenium by the Watkinson method.
Acute Toxicity Study
During the course of the exhalation study it was discovered that
TMSeCl was toxic if injected at high selenium levels.

An experiment

was performed in which 30 rats averaging 138 g were divided into 5
groups of 6 rats each. Each group was injected with a different level

of Se/kg body wt. The levels used were 40, 45 , 50 , 55, and 60 mg Se/kg.

These levels were used since preliminary work indicated the LD5 o lay

between 40 and 60 mg Se/kg. Toxic symptoms and gross pathology of those

rats which died were observed .for comparison with the symptoms and
pathology associated with selenite and selenate toxicity.
Chronic Toxicity Study
Two experiments were conduc�ed with weanling · rats to de�ermine
the effect of feeding TMSeCl.

Rats were randomly assigned to a

particular group except that certain adjustments were made to obtain an
approximately equal average w�ight for each group. The animals were
housed in individual. stainles s steel cages in an air conditioned room ,
given food and water � l ibitum throughout the experiment, and weighed
at weekly intervals.
The purpose of experiment 1 was to determine if TMSeCl could
produce chronic selenosis. Twenty rats (50-60 g) were divided into
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4 groups of 5 rats each.

Group 1 served as a basal diet control and

received only the basal diet.

Group 2 served as a standard for

comparison of selenium toxicity and received the basal diet plus 9 ppm
selenium as sodium selenite.

Group 3 received the basal diet plus 9

ppm selenium as TMSeCl. Group 4 received the basal diet plus JO ppm.
selenium as TMSeCl. The experiment was terminated at the end of the
fourth week. At that time all rats were killed

and

the livers removed

and weighed. Gross pathology of the rats was again observed and
· comparis·ons made between the various groups.
The purpose of experiment 2 was to determine the repeatability
of experiment l and, in addition, to study the effect of adding arsenic

to the di et of rats fed ™SeCl. This experiment consisted of 6 groups

of 5 rats (40- 5 0 g).

Group 1 served as the basal diet control.

Group

2 served as the standard for selenium toxicity and received the basal
diet plus 10 ppm sele�ium as sodium selenite. Group 3 received the
basal diet plus 10 ppm - selenium as TMSeCl.

Group 4 received the basal

diet plus 3_0 ppm selenium as TMSeCl_. Group 5 served · as the arsenic
control and received the basal diet plus 1 0 ppm arsenic as sodium
arsenite.

Group 6 received the basal diet plus 30 ppm selenium as

TMSeCl and 10 ppm arsenic as sodium arsenite. The experiment· was
conducted exactly as experiment l in all respects with the exception of
the slightly h igher selenium levels.
Urinary Excretion Study

tl !1,. 2

This study was an extension of �he study reported by Palmer
and was desig ned to determine whether arsenic a ffects the
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urinary excretion of TMSe by rats receiving relatively high levels of
sodium selenite.

Two groups of 6 r ats each averaging 137 g were used.

The control group was injected wi th a single dose of radioactive
selenite by intraperitoneal injection.

Each dose contained approxi

mately 100 microcuries of r adioactive selenium (H27 5se03) and

sufficient carrier sodium selenite to equal 2 mg Se/kg body wt.

The

second group received the selenium injection, but in addition they
received an intraperitoneal injection of sodiu.s.� arsenite (4 mg As/kg
· body wt. ) 10 min. prior to the selenium injection.

After injection,

the rats were placed in stainless steel metabolism cages and urine was
collected at 8-hour intervals over a 24-hour period.

No food was given

during the collection period, but tap water was available _!2, libiturn.
The amount of TMSe excreted was deter�ined by subjecting aliquot
portions (3 0 -5 0 microliters) of 75 se-containing rat urine to two

dimensional paper chro�atography on Whatman No. l paper (46 cm X 57
cm).

The paper was developed in the: first dimension with phenol-water.

(73 : 27 w/w) and in the second dimen�ion with n-butanol-acetic acid
water (4:1: 1, by vol. ) .

The radioactive TMSe metabolite was located

on the paper by c ochromatographing approximately 20 micrograms of known
TMSeCl with the urine aliquot.

The known TMSeCl was then located by

spraying the paper with the Munier and Machenhoeuf modific�ti on of
.

2
Dragendorf' s Reagent34 as described by Palmer � al • •

The colored

spot obtained (a pinkish orange) was then cut from the paper and
counted in a Packard well-type· scintillation counter. Total 75 se in
the u rine was determine� by counting aliquots of each sample.
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RESULTS
Exhalation Study
'Ihe results in Table I and Fig. 1 show that the amount of
exhaled selenium is very much less when selenium is injected as ™5eCl
than when injected as sodium selenite.

'lhe data also show that as the

selenium level, as Ti�SeCl, is increased the percentage of selenium
exhaled increases for a time but then begins to decrease as the level
of selenium approaches an acutely toxic dose (see section below on the
acute toxicity of TMSeCl) .
In the cases where the level of selenium is relatively low and
in cases where selenium levels are near the acutely toxic level, there
appears to be a cessation of the exhalation of volatile selenium
between J and 6 hours. At intermediate levels exhalation of volatile
selenium continues even up to 6 hours, but the rate of production of
the volatile compound( s) decreases continuously.
Table I and Fig. 2 show the. effect of sodium arsenite on the
exhalation of selenium• . Althoug� the rats did not live 6 hours at the
levels injected (because of the synergistic effect of arsenite on
TMSeCl toxicity), the results indicate that arsenite increases the
exhalation of selenium.
apparently true .

At least at low levels of selenium this is

The level of arsenic injected at constant selenium

levels also affects the percentage of selenium exhaled .

Table I. Selenium Exhalation by Rats Following Injection of TMSeCl and Effect of Simultaneous
Injection of Sodium Arsenitea.
Selenium
Injection
Form
. Selenite
TMSeCl
TMSeCl
TMSeCl
TMSeCl

In,jection Dosage

mg Se/kg

body wt.

1.5

mg Nl/k g

body wt'.

1.5

1

6. 7

15. 0

30 . 0

1 .9

4. 9

2. 0

1 3. 4c

TMSeCl

1. 5

2. 0

4.5

TMSeCl
a
b
c
d

Data are
Datum is
Data are
Data for

40. 0

4. 0

4

3.5
6.2

0. 75

4. o

3
19 . 5

3. 2
1. 3b

40. 0

1. 5

2

1.9

TMSeCl
TMSeCl

Selenium Exhaled ( % injected dose)
Hours after injection

2. 4C

7. 6

3 . 9c

7. 4d

8. ld

12 . 3 °

l. ld

J. 8d

30 . 0
3.3

2.9

6.8

;

6 .5

4. J

averages for three rats unless otherwise indicated.
average for five rats.
averages for two rats.
only one r_at.
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Acute Toxicity Studl
The results of Table II indicate that the approximate LD5 0 of

TMSeCl for the rat is 48 mg Se/kg body wt.

The symptoms of TMSeCl

poisoning observed after injection of an acutely toxic dose were very
nearly the same as those described by Franke and Moxon18 •

The gross

pathology of dead rats was similar to that described by Jones26 .

The

pliable liver condition was hard to evaluate, however. Not all rats
showed the same symptoms or pathology nor did the y all show the
symptoms and pathology to the same degree.
As mentioned above, arsenite was found to exert a synergistic
effect on TMSeCl toxicity_. This is in conflict wi th what has been
reported for other forms of selenium. To the author ' s knowledge, this
is the first report of the synergistic effect of arsenite on selenium
toxicity.

kn LD50 determination for rats injected with various levels

of TMSeCl plus 4 mg As/kg body wt. was carried out.
given in Table III.

The results are

The approximate LD50 was found to be 9.7 mg Se/kg

body wt. There · is ·evidence to suspect that this value · may vary with the level of arsenic injected.

The arsenite injections preceded the

selenium injections by 10 min.

The criterion used for _ the determination of the LD50 in either
case was the level of seleniu.� that would cause death to 50% of those
injected in 4 hours. It is important to note that the rats injected

with only TY!SeCl died soon (within 1 hour ) after injection or not at
al.l. The rats injected with TMSeCl plus arseni te very seldom died

before 1 hour. Once they beg_an sho·wing the toxic Symptoms they lived
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Table II.
Methoda .
Dose
mg Se/kg
body wt.
40

Calculation of LD5 0 of TMSeCl for the Rat by the Dragstedt
Results in 4 Hours
Died
Lived
0
6

Cumulative
Lived
Died
0
13
1

f, Mortality

o.oo

12. 5

45

5

l

7

50

2

4·

2

55

0

6

0

11

100

60

0

6

1

17

100

5

71 .5

a This method has often been attributed to Reed and Muench35, ·who
devised a �imilar procedure. The method was actually worked out by
Dragstedt:3 6 •
Table
Rat.

III .

Dose
mg Se/kg
body wt. a

Effect of Sodium Arsenite on the LD50 of TMSeCl for the
Results in 4 Hours
Died
Lived
2
4

Cumulative
Lived
Died
16 .
4

'%, _ Mortality
20. 0

4-

2

14

6

30 . 0 ,.

3

J

10

9

4

2

7

11

47 . 5

3

J

J

14

61. 0
82.-4

a Intraperitoneal injection of 4. 0 mg As/kg body wt. preceded the
TMSeCl injection by 10 min.
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only 10-15 min. longer, however .

In addition to the gross pathology

observed for rats injected with TMSeCl, those rats that died from the
TMSeCl plus arsenite injections showed what appeared to be massive
hemorrhaging in the lungs.
The method used to establish the LD50 did not permit an estima
tion of the accuracy of the answer �alculated3 6 • It is the opinion of
this investigator that this information would be of no practical val�e.
The value of the LD50 for TMSeCl is sufficiently different from that
obtained for TMSeCl _plus arsenite that no statistical analysis is
necessary to prove a treatment effect.

Thi s same reasoning can be

applied when one compares the LD50 value for TMSeCl with the LD50

values that could be predicted for selenite or selenate .
Chronic Toxicity Study

The data in Table IV summarize the results of feeding TMSeCl
and the effect of adding sodium arsenite to a diet containing T}!SeCl.
In neither experiment is there a significant difference in weight gain
or liver wt. /100 g body . wt . betw�en the control group and the groups
receiving diets other than those containing selenite (as determined

by Dunnett ' s test3 7 ).

No gross pathology was observed in any rats,

with the exception of the selenite-fed rats which showed the
characteristic liver necrosis, jaundice, and in some cases anemia
associated with chronic selenosis.
At the levels of selenium and arsenite used, W.LSeCl was not
toxic when ingested orally and there was no synergistic effect when
arsenite was added to a diet containing TMSeCl.

. Ji

Table IV.

Chronic Toxicity or TMSeCl and Effect of Added Sodium Arsenite.

Treatment
Basal
Basal
as
Basal
as
Basal
as
Basal
Basal
as
Basal
as
Basal
as
Basal
as
Basal
as
As

�
c
*

diet
diet+9 ppm Se
selenite
diet+9 ppm Se
THSeCl
diet+J0 ppm Se
TMSeCl
diet
diet+l0 .PPM Se
selenite
diet+l0 ppm Se
TMSeCl
diet+J0 ppm Se
TMSeCl
diet+l0 ppm As
arsenite
diet+J0 ppm Se
TMSeCl+l0 ppm
as arsenite

Fourth
Week

Liver Weight a
per 100 g
body wt.

58. 0±4.2b
58. 3±2.2

Bodl Wei ghta
Third
Second
First
W:eek
Week
Week
Experiment l
113.0±14.4
157.2±17.1
77 � 7±8.7
58.0:tJ.2*
74.2± 6.1*
99 - 7± 7.1•

196. 6:t22. 8
127.l:tl5. 0*

4.2LH--0.16
3. 36t().95*

57.1±2.0

78.2±3- .5

lll.9 :t 9.8

146.3:rl8.3

185.l:t20. 8

4. 33±0. 31

55.6±1 - 7

73 - 3±2.6

105.9± 4. 6

149.2:t 1.3

187.7+ 3. 6

4.55:t0.17

49 -5:r2� 3
48.9:t.-l.9

Experiment 2
76�2:t6. 3
111.3:t 9.3
47.3:t.5 - 3 *
58.8:r 6.6*

155.7:t-1 6.o
78. 5:t 9. 8 *

202.8±21 • .5
91. 6:t21.0 *0

.5 - 53±().48
J.22:tl.2J*C

48. 7:t-2. 8

75.2:tJ.6

112. 3:t 7.9

156.6± 9.4

204.O:rl2.6.

5 75:t0 - 27

,50.2:H.9

76.6±1. 6

113.6:t- 4.6

154. 3:t 8. 8

199. 3:tl0.5

5.97±().51

49.5:rl. 3

7602:tJ. 4

ll4. 6t 4. 8

156. 7:t 7. 9

201. 3:t 6.9

5.19:r0. 52

109.0:t 6.8

149.6±11. 0

192.2zlJ. 4

5. 67!t(). 82

Start

50.5:t2.2

7 7 .1:tJ • .5

-

♦

Represents average of five rats unless otherwise indicated. Weights in g.
Mean:tstandard deviation.
Represents average of four rats. One rat died two days prior to termination of experiment.
Significantly different from the basal diet group ( P <0 . 05 ) by Dunnett ' s test37.
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Urinary Excretion Study
The data in Table V indicate that the group receiving selenite
plus arsenite excreted a lesser amount of 75 se than did the group
receiving only selenite.
determined by 1 1 t 11 test37.

The difference was highly significant as
The data also indicate that a significantly

lesser amount of 75se in the form of TMSe was excreted for the group
receiving selenium plus arsenite than for the group receiving selenite
alone, again as determined by "t" test.
Fig. J shows clearly that the significantly different results
are· observed only in the first 8-hour period.

Later time periods

showed no significant difference in the results for the two groups.
The 8-hour period differences were large enough so that a st atistically
significant difference was obtained over the entire 24-hour collection
period when the data were combined.

Table V. Effect of Sodium Arsenite on the Urinary Produc tion of TMSe From Rats- Injected With ( 75 se)
Selenitea.
Collection
Interval
Hours
After
Injection

Se onlyb

0-8

10. 5+1.4d

Of the injected dose

-

% 75 se

Se+Asc
?. O:tl. l**

recovered in the urine
In the form of TMSe
� of in,jected dose
of urinar;y: Se
Se+As
Se only
Se+As
Se only
Rate Study
2. 8t0. 2**
40. 3±4. 0
4.4to . 9
42. 2±11. 6

%

8-16

6.11:1.0

5. 4±0. 7

40. 3± 5 .9

40. 6±2. 4

2.4-zo. 4

2. 2±0 - 3

16-24

4.5:tO .-5

4. 7±<) �8

35. J± 5. 4

31. 0±2. 8

1. 6±0. 2

1. 5:ta. 4

40. 3±4.0

4.4to.9

2. 8±(). 2 **

0-8

10. 5±1.4

7 • 0±1. l**

Totals
42.2±11. 6

0-16

16. 6,zl.9

12.4±1. 6**

38. 8± 2. 8

38. 0±2. 8

6. 8:tl.2

5. 0:t<). 6**

0-24

21. 2±1.9

1 7 . 2±1. 6**

37 - 5± 7. 2

35 - 5±1. 9

8.4±1. 3

6. 5±0. 6*

a Averages for six rats. ·
b 100 microcuries 75 se and additional · sodium selenite to make injection dose of 2. 0 mg Se/kg
body wt.
� Dose of 4. 0 mg A:3/kg body wt. preceded the selenite injection by 10 min.
Mean+standard deviation.
* Sig;ificantJ.y different from the selenite only group ( P <0. 0.5) by 11 t" test37.
** Highly significantly different from the selenite only group ( P<0. 01).
\..J
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DISCUSSION
The level at which TMSeCl is toxic is high rel a.tive to that
reported for other forms of selenium ,

i•�• ,

MLD for selenite and

selenate is 3 .5 mg and 5. 3 mg, respective1yl8 , MLD for dl-selenocystine

and selenomethionine is 4.0 mg and - 4.25 mg, respective1y22, 2 3 . If one

were to postulate that the toxicity of these compounds is due to their
conversion to the TMSe moiety, then one must also postulate that they
all go through a common intermediate on their way to conversion to
TMSe.

If this were not true, then one should observe a greater degree

of variation in the toxic dose of each.

Further, ·there must be a rate

limiting step in the pathway, either the formation of this postulated
intermediate itsel f or a step between the common intermediate and
TMSe.

A question immediately arises--if TMSe moiety is the toxic

substance involved for all of these compounds, why is it necessary to
inject TMSeCl at such high levels in order to get a toxic response?
The proof of this hypothesis· will have to provide the · answer to this
question.
The synergistic effect of arsenite on TMSeCl is in direct
opposition to what has been reported for other forms of selenium. It
is the belief of this investigator that the observed results are a
synergistic effect and not a summation effect because the toxic
symptoms for rats injected with TMSeCl plus arsenite are the same as
those observed when TMSeCl is injected alone.

Since the mechanism by

which arsenic exerts its effect on selenium metabolism is unknown, one

J4
cannot say with certainty that it is exerting itself differently
when Tl'1SeCl is injected than when selenite is injected.
After completion of the toxicity studies for TMSeCl, it was
. thought necessary to compare the toxicity of TMSeCl with trimethylL
sulfonium chloride ( TMSCl ) to verify that the observed toxicity was
in fact due to the unique presence of selenium and not to a particular
chemical structure,

i•�• •

the trimethyl -onium structure.

Injection of

TMSCl in the same manner as TMSeCl produced the same toxic symptoms and
death as observed fo.r TMSeCl.

Arsenite was also found to have the

same synergistic effect on THSCl as it has on TMSeCl.

Hunt and

Renshaw38 studied the effect of trimethylsulfonitun iodide (Tl1SI ) on
the autonomic nervous system of cats and found that TMSI has both
muscarinic and nicotinic action.

Their criterion for muscarinic

action was taken as a fall of blood pressure which was prevented by
small doses of atropine (but not by nicotine or by section of the
vagi) .

Their criterion for a nicotinic action ..,as taken a s a rise of

blood pressure with � frequently, an acceleration of the heart in an

animal in which the brain· and uppe� spinal cord had been _ destroyed and

which was prevented by a l arge dose of nicotine but not by atropine.
The approximate fatal dose of TMSI for mice was found to be 33 mg S/kg
body wt.

Muscarine, from which the term muscarinic action gets its

name, exerts effects very similar to those of acetylcholine on smooth
muscle, cardiac muscle, and.exocrine gl ands39 . Sollman40 in describing
the action of muscarine on the frog heart states that muscarine causes
slowing, with diminished systolic and increased cliastolic excursions,
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and finally stoppage in diastole. Muscarine is reported to cause
acute excitement and violent delirium40.

Nicotine, from which the

term nicotinic action gets its name, has both centrol. nervous system
and peripheral actions, both of which are important.

Cen�rally, small

doses cause chiefly a respiratory stimulation ; larger doses produce
·-

convulsions of the medullary type and arrest of respiration. The
action is rapid, approaching that of hydrocyanic acid. Peripherally,
nicotine paralyzes all autonomic ganglia, parasympathetic as well as
sympathetic.

The paralysis may be preceded by stimulation.

Nicotine

has several distinct actions on striated muscle, including fibrillary
twitchings, curare action, and tonus40 .
Because the symptoms of TMSeCl toxicity and the gross pathology
of dead animals are compatible with what one could predict for compounds
having muscarinic a:nd/or nicotinic action and, since TMSI has been
proved to have these �roperties, it seems credible that TMSeCl toxicity ·
may be due to these same actions.

This investigator proposes that this

may be the case and that TMSeCl toxicity may not be caused by the
unique presence of selenium but rather may be a general property of
most compounds with that same g eneral structure. It is .also possible
that the toxicity of selenite--and, indeed, a.11 foms of s�lenium--is
due to the formation of the TMSe moiety because the symptoms and
pathology are similar.
This explanation whi�e answering -some of the questions that have
arisen from the voluminous data on selenium metabolism does not answer
them all. In fact, several factors are still unexplainable, !.• .!• • the

J6
effect of arsenic on selenium metabolism.
disprove the proposal given.

This , in itsel f, does not

The establishment or ' the metabolic

pathway, including the enzymology, may confirm this theory.
The theory does provide a basis for explaining the very low
exhalatio11 of volatile selenium when TMSeCl is injected as compared to
selenite.

If TMSeCl is assumed to have the nicotinic action of TMSI,

then a large dose would suppress respiration, thereby decreasing
exhalation of volatile selenium.

On the other hand, if one assumes

that the volatile selenium product ( s) is on the pathway to TMSe pro
duction , then the nonreversibility of the step( s ) leading from
volatile product( s) to TMSe could alone explain the lowering of volatile
selenium.

This latter explanation is satisfactory up to a point, but

one then wonders why this nonreversibility manifests itsel f les s at
40 . 0 mg Se than at JO. O mg or 15 . 0 mg.

If formation of volatile

selenium from TMSe is a spontaneous process, logic ·would predict that
more volatile product would be formed if a higher dose is injected.
.
.
The propos�d theory offers a better ex:plan.ation for ·the observed data�
!_. _g. , a rise in volatile ·selenium as the level of selenium increases up
to 15. 0 mg Se and then a decrease.

The depression of respiration would

be greater the larger the dose. of TMSeCl.

The apparent cessation of

exhalation of volatile selenium at 1.5 mg Se may not be a result of the
propo sed nicotinic action.

Tsay1U working with radioactive T�eCl at

0. 1 mg Se/kg body wt. found _ that the major fraction of the TMSe was
excreted in the urine.

Therefore, at low levels TMSe may be e�creted

fast enough to reduce volatilization.

At higher levels , renal
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excretion may not operate rapidly enough and thus increased volatiliza
tion would occur up to the point that TMSe inhibits respiration.
An explanation for the failure of TMSeCl to s how toxic effects
when given orally is that the compound may not be absorbed from the
digestive tract. Additional work in this area is necessary to verify
the validity of this h ypothesis .
The biological significance of the decreased TMSe production
from rats injected with selenite plus arsenite is doubtful. The results
are statistically significant , but this is probably not of any real
value in explaining the decrease in selenite toxicity by arsenite since
the magnitude of the differences was rather small .

The similar decrease

in urinary selenium is itself sufficient expl anation for the decreased
TMSe observed.
The effects of arsenite on exhalation and toxicity are particu
larly hard to explain as they are exactly opposite to what has been
reported for other forms of selenium. studied. Arsenite was also found
to increas� the toxicity of dimethyl selenide as much as 200-fold
(unpublish ed data of this investigator).

The discovery of the

mechanism of action of arsenic on selenium metabolism will surely do
much to elucidate the pathway of selenium.
This investigation did not study the complete metabolism of
T11SeCl. Further studies should include fecal elimination and body

retention studies. Such studies should. provi de evidence of the
validity of the proposal made as to TMSeCl toxicity.
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SUNMARY

Trimethylselenonium chloride is toxic to rats when administered
by intraperitoneal injection but at much higher selenium levels than
required for selenite.

The LD5 0 is 48 mg Se/kg body wt.

The toxic

symptoms and gross pathology are very similar to those produced by
selenite.

The hypothesis was suggested that the toxicity of TMSeCl may

be due to a muscarinic and/or a nicotinic action which similar compounds,
i•!:.•, trimethylsulfonium iodide, have been shown to produce.

When

administered in the . diet at levels up to JO ppm TMSeCl is not toxic.
TMSeCl is not metabolized to a volatile product( s) as readily
as selenite.

This implies that exhalation probably is not an important

route of excretion for the removal of this toxic material from the
body.

The · effect of arsenite on TMSeCl metabolism is exactly opposite

that reported for other forms of selenium.
toxicity of TMSeCl.
selenide.

Arsenite increases the

°This was a.lso found to be true for dimethyl

�he LD5 0 for TMSeCl Elus arsenite ( 4. 0 mg As/kg body wt. )

is 9. 7 mg Se/kg body wt.

Arsenite also increases the exhalation or ·

volatile selenium compound( s) after TMSeCl injection.

Arsenite does

not have a synergistic effect on TMSeCl toxicity when both are given
orally as dietary supplements.

Arsenite lowers the urinary production

of TMSeCl by rats administered selenite by a statistically significant
amount.

It is doubtful that this is of _ any real value in explaining

the protective effect of arsenite against selenite toxicity as the
differences are not large.
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Additional experiments to include fecal and re tention studies
are nece s s ary to con1pl ete the inve stigation of th e metaboli sm of

TMSeCl.
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